摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(6-methoxy-1-oxoisoindolin-2-yl)-N-(4-(piperazin-1-yl)pyridin-3-yl)furan-2-carboxamide | 1268389-46-3

中文名称
——
中文别名
——
英文名称
5-(6-methoxy-1-oxoisoindolin-2-yl)-N-(4-(piperazin-1-yl)pyridin-3-yl)furan-2-carboxamide
英文别名
5-(5-methoxy-3-oxo-1H-isoindol-2-yl)-N-(4-piperazin-1-ylpyridin-3-yl)furan-2-carboxamide
5-(6-methoxy-1-oxoisoindolin-2-yl)-N-(4-(piperazin-1-yl)pyridin-3-yl)furan-2-carboxamide化学式
CAS
1268389-46-3
化学式
C23H23N5O4
mdl
——
分子量
433.467
InChiKey
LFGWNQSSZYYRPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    32
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    99.9
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC AMIDE COMPOUNDS AS PROTEIN KINASE INHIBITORS
    申请人:Reddy Panduranga Adulla P.
    公开号:US20120208826A1
    公开(公告)日:2012-08-16
    The present invention relates to heterocyclic amide derivatives of Formula (I): Formula (I) wherein the variables are as defined in the specification. The present invention further relates to compositions comprising said heterocyclic amide derivatives of formula (I) and methods for using said heterocyclic amide derivatives of formula (I) for treating or preventing a disease or disorder related to the activity of a protein kinase, in particular, a proliferative disease, an anti-proliferative disorder, inflammation, arthritis, a neurological or neurodegenerative disease, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease or a fungal infection.
    本发明涉及式(I)的杂环酰胺衍生物:式(I)其中变量如规范中所定义。本发明还涉及包含式(I)的上述杂环酰胺衍生物的组合物以及使用式(I)的上述杂环酰胺衍生物治疗或预防与蛋白激酶活性相关的疾病或障碍的方法,特别是增生性疾病、抗增生性障碍、炎症、关节炎、神经系统或神经退行性疾病、心血管疾病、脱发、神经疾病、缺血性损伤、病毒性疾病或真菌感染。
  • Heterocyclic amide compounds as protein kinase inhibitors
    申请人:Reddy Panduranga P. Adulla
    公开号:US08669259B2
    公开(公告)日:2014-03-11
    The present invention relates to heterocyclic amide derivatives of Formula (I): Formula (I) wherein the variables are as defined in the specification. The present invention further relates to compositions comprising said heterocyclic amide derivatives of formula (I) and methods for using said heterocyclic amide derivatives of formula (I) for treating or preventing a disease or disorder related to the activity of a protein kinase, in particular, a proliferative disease, an anti-proliferative disorder, inflammation, arthritis, a neurological or neurodegenerative disease, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease or a fungal infection.
    本发明涉及公式(I)的杂环酰胺衍生物:公式(I)其中变量如规范中定义。本发明还涉及包含公式(I)的杂环酰胺衍生物的组合物以及使用公式(I)的杂环酰胺衍生物治疗或预防与蛋白激酶活性相关的疾病或障碍的方法,特别是增殖性疾病,抗增殖性疾病,炎症,关节炎,神经或神经退行性疾病,心血管疾病,脱发,神经元疾病,缺血性损伤,病毒性疾病或真菌感染。
  • US8669259B2
    申请人:——
    公开号:US8669259B2
    公开(公告)日:2014-03-11
  • [EN] HETEROCYCLIC AMIDE COMPOUNDS AS PROTEIN KINASE INHIBITORS<br/>[FR] COMPOSÉS D'AMIDE HÉTÉROCYCLIQUE COMME INHIBITEURS DE LA PROTÉINE KINASE
    申请人:SCHERING CORP
    公开号:WO2011025706A3
    公开(公告)日:2011-05-05
查看更多